“…More than 1000 different antimicrobial peptides have been documented with activity against viruses, bacteria, and fungi, prompting interest in using the structural principles of small cationic, amphiphilic molecules for improving and fine tuning target specificity and efficacy (3)(4)(5)(6). Non-natural multivalent AMPs have been designed by conjugating copies of a peptide monomer to scaffold molecules via naturally occurring intermolecular disulfide bridges or unnatural scaffold linkers (7). Branched peptides have been shown to have considerable advantages over their monomeric forms, such as improved antimicrobial activity (8), maintaining high efficacy under physiological (high salt) conditions (9,10), enhanced bacterial surface binding affinity (11), decreased susceptibility to proteolytic degradation (12,13), and low cytotoxicity (14,15).…”